TuHURA Biosciences (HURA) News Today $4.11 -0.09 (-2.14%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$4.04 -0.07 (-1.58%) As of 04/15/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period HURA: 2024 Financial ResultsApril 14 at 11:43 AM | msn.comTuHURA Biosciences hires new EVP for drug developmentApril 9, 2025 | uk.investing.comTuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual MeetingApril 8, 2025 | prnewswire.comQ2 EPS Estimate for TuHURA Biosciences Increased by AnalystTuHURA Biosciences (NASDAQ:HURA - Free Report) - Stock analysts at HC Wainwright upped their Q2 2026 earnings per share (EPS) estimates for TuHURA Biosciences in a research note issued on Thursday, April 3rd. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per sApril 8, 2025 | marketbeat.comTuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program ManagementApril 7, 2025 | prnewswire.comQ2 EPS Estimate for TuHURA Biosciences Raised by AnalystApril 7, 2025 | americanbankingnews.comEquities Analysts Set Expectations for HURA Q3 EarningsTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for TuHURA Biosciences in a report issued on Thursday, April 3rd. HC Wainwright analyst R. Burns forecasts that the company will earn ($0.10) per shApril 6, 2025 | marketbeat.comTuHURA Biosciences (NASDAQ:HURA) Given New $12.00 Price Target at HC WainwrightApril 6, 2025 | americanbankingnews.comWhat is HC Wainwright's Estimate for HURA Q3 Earnings?April 6, 2025 | americanbankingnews.comHC Wainwright Cuts TuHURA Biosciences (NASDAQ:HURA) Price Target to $12.00HC Wainwright cut their price objective on shares of TuHURA Biosciences from $13.00 to $12.00 and set a "buy" rating for the company in a report on Thursday.April 5, 2025 | marketbeat.comIs TuHURA Biosciences (NASDAQ:HURA) In A Good Position To Deliver On Growth Plans?April 2, 2025 | finance.yahoo.comTuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate UpdateApril 1, 2025 | prnewswire.comTuHURA Biosciences (NASDAQ:HURA) Stock Price Up 1.7% - Still a Buy?TuHURA Biosciences (NASDAQ:HURA) Shares Up 1.7% - Should You Buy?March 28, 2025 | marketbeat.comTuHURA Biosciences Announces Acquisition of Kineta, Inc.March 18, 2025 | msn.comTuHURA Biosciences appoints Craig Tendler to board of directorsMarch 11, 2025 | markets.businessinsider.comTuHURA Biosciences, Inc. to Present at the 37th Annual ROTH ConferenceMarch 10, 2025 | gurufocus.comQ2 Earnings Estimate for HURA Issued By HC WainwrightTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities researchers at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of TuHURA Biosciences in a report issued on Monday, March 3rd. HC Wainwright analyst R. Burns expects that the company will earn ($0.20) per share foMarch 7, 2025 | marketbeat.comTuHURA Biosciences initiated with a Buy at H.C. WainwrightMarch 4, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of TuHURA Biosciences (HURA) with Buy RecommendationMarch 4, 2025 | msn.comTuHURA Biosciences (NASDAQ:HURA) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright began coverage on TuHURA Biosciences in a report on Monday. They set a "buy" rating and a $13.00 price objective for the company.March 3, 2025 | marketbeat.comSuncoast Equity Management Buys Shares of 102,997 TuHURA Biosciences (NASDAQ:HURA)Suncoast Equity Management purchased a new position in TuHURA Biosciences (NASDAQ:HURA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 102,997 shares of the company's stock,February 22, 2025 | marketbeat.comTuHURA Biosciences (HURA) to Release Earnings on WednesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comTuHURA Biosciences: A Hold On Only The Faintest Glimmers Of EfficacyFebruary 16, 2025 | seekingalpha.comApollon Wealth Management LLC Acquires New Stake in TuHURA Biosciences (NASDAQ:HURA)Apollon Wealth Management LLC acquired a new stake in shares of TuHURA Biosciences (NASDAQ:HURA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 61,772 shares of the company's stock, valued at approximately $253,000. ApolloFebruary 15, 2025 | marketbeat.comQ2 Earnings Estimate for HURA Issued By Zacks Small CapTuHURA Biosciences (NASDAQ:HURA - Free Report) - Analysts at Zacks Small Cap issued their Q2 2025 earnings estimates for TuHURA Biosciences in a report released on Tuesday, February 4th. Zacks Small Cap analyst J. Vandermosten anticipates that the company will post earnings of ($0.09) per share fFebruary 5, 2025 | marketbeat.comHURA: Initiating an Immune ResponseFebruary 5, 2025 | msn.comTuHURA Biosciences (HURA) Projected to Post Quarterly Earnings on WednesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Wednesday, February 12, Financial Modeling Prep reports.February 5, 2025 | marketbeat.comTuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% - Here's What HappenedTuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% - What's Next?January 31, 2025 | marketbeat.comWhen Can We Expect A Profit From TuHURA Biosciences, Inc. (NASDAQ:HURA)?January 18, 2025 | uk.finance.yahoo.comRep. Laurel M. Lee Buys TuHURA Biosciences (NASDAQ:HURA) SharesRepresentative Laurel M. Lee (R-Florida) recently bought shares of TuHURA Biosciences (NASDAQ:HURA). In a filing disclosed on January 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in TuHURA Biosciences stock on November 25th. Representative Laurel M. Lee also reJanuary 9, 2025 | marketbeat.comTuHURA Biosciences Inc HURAJanuary 2, 2025 | morningstar.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of ShareholdersDecember 20, 2024 | globenewswire.comTuHURA Biosciences (NASDAQ:HURA) Rating Increased to Strong-Buy at RODMAN&RENSHAWRODMAN&RENSHAW upgraded shares of TuHURA Biosciences to a "strong-buy" rating in a research note on Thursday.December 20, 2024 | marketbeat.comRodman & Renshaw Begins Coverage on TuHURA Biosciences (NASDAQ:HURA)Rodman & Renshaw assumed coverage on TuHURA Biosciences in a research note on Thursday. They set a "buy" rating and a $11.00 target price for the company.December 19, 2024 | marketbeat.comTuHURA Biosciences initiated with a Buy at Rodman & RenshawDecember 18, 2024 | tipranks.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating TuHURA Biosciences, Inc. MergerDecember 13, 2024 | markets.businessinsider.comTuHURA Biosciences to Acquire Kineta, Inc. in 2025December 13, 2024 | markets.businessinsider.comTuHURA Biosciences enters definitive merger agreement to acquire KinetaDecember 12, 2024 | markets.businessinsider.comKineta Merges with TuHURA to Enhance Cancer TreatmentDecember 12, 2024 | markets.businessinsider.comHURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to ShareholdersDecember 12, 2024 | tmcnet.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURADecember 12, 2024 | prnewswire.comTuHURA Biosciences to acquire KinetaDecember 12, 2024 | seekingalpha.comTuhura Biosciences Inc Share Price (HURA.US)December 7, 2024 | lse.co.ukTuHURA Biosciences Advances in Cancer Immunotherapy InnovationsNovember 25, 2024 | tipranks.comTuHURA Biosciences outlines development pathway for IFx-2.0November 25, 2024 | tipranks.comRep. Laurel M. Lee TuHURA Biosciences (NASDAQ:HURA) StockRepresentative Laurel M. Lee (R-Florida) recently bought shares of TuHURA Biosciences (NASDAQ:HURA). In a filing disclosed on November 21st, the Representative disclosed that they had bought between $100,001 and $250,000 in TuHURA Biosciences stock on October 18th. Representative Laurel M. Lee alsoNovember 24, 2024 | marketbeat.comTuHURA Biosciences Inc (HURA)November 23, 2024 | investing.com Remove Ads Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address HURA Media Mentions By Week HURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HURA News Sentiment▼0.770.78▲Average Medical News Sentiment HURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HURA Articles This Week▼42▲HURA Articles Average Week Remove Ads Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRAX News Today OCS News Today CDXC News Today NUVB News Today ABCL News Today CVAC News Today XNCR News Today PRTA News Today REPL News Today ABUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HURA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.